• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初步结直肠肿瘤筛查阳性者中与结肠镜检查依从性相关的因素。

Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.

机构信息

Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou, Guangzhou, P. R. China.

Shenzhen Hospital, Southern Medical University, Shenzhen, P. R. China.

出版信息

Cancer Med. 2022 Nov;11(22):4321-4331. doi: 10.1002/cam4.4730. Epub 2022 Apr 20.

DOI:10.1002/cam4.4730
PMID:35441812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9678100/
Abstract

OBJECTIVES

This study aimed to investigate the potential factors associated with adherence to colonoscopy among participants who were preliminarily screened positive in a community-based colorectal cancer screening program in China.

METHODS

This study analyzed data from 1219 out of 6971 community residents who were identified as positive cases by the well-validated high-risk factor questionnaire (HRFQ) or fecal immunochemical test (FIT) in the preliminary screening stage for colorectal neoplasms. Patients showing adherence to colonoscopy were defined as those who received positive results in a preliminary screening for colorectal neoplasms and later received a colonoscopy examination as required. The associations of social-demographic factors, lifestyle behaviors, history of diabetes, body mass index (BMI), and risk factors in the HRFQ with adherence to colonoscopy were evaluated using logistic regression models.

RESULTS

Among 1219 participants who preliminarily screened positive, the top five risk factors reported by the participants were chronic constipation (25.9%), hematochezia (23.5%), family history of CRC in first-degree relatives (22.1%), chronic diarrhea (21.8%), and history of polyps (16.6%). Around 14.2% of participants who preliminarily screened positive reported three or more risk factors, and the proportion was 26.2% among participants who were positive according to both HRFQ and FIT. Among all participants who were preliminarily screened positive, the multivariable results showed that those who were married (OR = 1.58, 95% CI: 1.12, 2.25, p = 0.01), had chronic diarrhea (OR = 1.34, 95% CI: 1.00, 1.78, p = 0.047), and had a positive FIT (OR = 1.60, 95% CI: 1.21, 2.10, p < 0.001 for patients who were negative according to HRFQ but positive according to FIT; OR = 2.12, 95% CI: 1.33, 2.78, p = 0.002 for patients who were positive for both HRFQ and FIT) were more likely to adhere to colonoscopy, while participants with a history of cancer (OR: 0.50, 95% CI: 0.31, 0.79, p = 0.003) were less likely to adhere to colonoscopy. The results among participants who were tested positive according to only HRFQ were similar to those among all participants who were tested positive according to HRFQ or FIT. However, among participants who were tested positive according to only FIT, we only found that those who were married (OR = 2.52, 95% CI: 1.08, 5.90, p = 0.033) had a higher odds of adhering to colonoscopy, while those with a history of diabetes (OR = 0.35, 95% CI: 0.13, 0.96, p = 0.042) were less likely to adhere to colonoscopy.

CONCLUSION

Our findings provide evidence supporting the development of tailored interventional strategies that aim to improve adherence to colonoscopy for individuals with a high risk of colorectal neoplasms. Both barriers and facilitators associated with adherence to colonoscopy should be considered in supportive systems and health policies. However, further well-designed prospective studies are warranted to confirm our findings.

摘要

目的

本研究旨在探讨中国社区为基础的结直肠癌筛查项目中初步筛查阳性者接受结肠镜检查的潜在相关因素。

方法

本研究分析了来自 6971 名社区居民的 1219 名参与者的数据,这些参与者通过有效的高危因素问卷(HRFQ)或粪便免疫化学试验(FIT)初步筛查结直肠肿瘤呈阳性。将接受结肠镜检查的患者定义为初步筛查结直肠肿瘤呈阳性,随后按要求接受结肠镜检查的患者。使用逻辑回归模型评估社会人口统计学因素、生活方式行为、糖尿病史、体重指数(BMI)和 HRFQ 中的风险因素与接受结肠镜检查的关联性。

结果

在 1219 名初步筛查阳性的参与者中,参与者报告的前五大风险因素依次为慢性便秘(25.9%)、血便(23.5%)、一级亲属结直肠癌家族史(22.1%)、慢性腹泻(21.8%)和息肉史(16.6%)。约 14.2%的初步筛查阳性者报告了三个或更多的风险因素,而 HRFQ 和 FIT 均阳性的参与者中这一比例为 26.2%。在所有初步筛查阳性的参与者中,多变量结果显示,已婚者(OR=1.58,95%CI:1.12,2.25,p=0.01)、有慢性腹泻者(OR=1.34,95%CI:1.00,1.78,p=0.047)和 FIT 阳性者(OR=1.60,95%CI:1.21,2.10,p<0.001,适用于 HRFQ 阴性但 FIT 阳性的患者;OR=2.12,95%CI:1.33,2.78,p=0.002,适用于 HRFQ 和 FIT 均阳性的患者)更有可能接受结肠镜检查,而有癌症史者(OR:0.50,95%CI:0.31,0.79,p=0.003)更不可能接受结肠镜检查。仅 HRFQ 阳性者的结果与 HRFQ 或 FIT 均阳性者的结果相似。然而,在仅 FIT 阳性的参与者中,我们只发现已婚者(OR=2.52,95%CI:1.08,5.90,p=0.033)接受结肠镜检查的可能性更高,而有糖尿病史者(OR=0.35,95%CI:0.13,0.96,p=0.042)接受结肠镜检查的可能性较低。

结论

我们的研究结果为制定针对结直肠肿瘤高危人群的个体化干预策略提供了证据。在支持系统和卫生政策中,应考虑与结肠镜检查依从性相关的障碍和促进因素。然而,还需要进一步设计良好的前瞻性研究来证实我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/0000be54b838/CAM4-11-4321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/a1c5f04fad1a/CAM4-11-4321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/3e45ee6788cd/CAM4-11-4321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/0000be54b838/CAM4-11-4321-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/a1c5f04fad1a/CAM4-11-4321-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/3e45ee6788cd/CAM4-11-4321-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b81c/9678100/0000be54b838/CAM4-11-4321-g004.jpg

相似文献

1
Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms.初步结直肠肿瘤筛查阳性者中与结肠镜检查依从性相关的因素。
Cancer Med. 2022 Nov;11(22):4321-4331. doi: 10.1002/cam4.4730. Epub 2022 Apr 20.
2
[Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].[高危因素问卷与亚太地区结直肠癌筛查评分及其与粪便免疫化学检测联合应用在筛查进展期结直肠癌中的效果比较]
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jul 25;25(7):612-620. doi: 10.3760/cma.j.cn441530-20211127-00478.
3
Combining FITs and HRFQ with colonoscopy improve the cost-effectiveness of a 9-year mass colorectal cancer screening program.联合 FIT 和 HRFQ 与结肠镜检查可提高 9 年大规模结直肠癌筛查计划的成本效益。
ESMO Open. 2024 Sep;9(9):103676. doi: 10.1016/j.esmoop.2024.103676. Epub 2024 Aug 20.
4
Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.中国结直肠肿瘤两步筛查策略中初筛阳性预测值的相关因素。
Discov Oncol. 2022 Jan 8;13(1):4. doi: 10.1007/s12672-022-00463-8.
5
Postponing colonoscopy for 6 months in high-risk population increases colorectal cancer detection in China.在中国高危人群中,将结肠镜检查推迟 6 个月会增加结直肠癌的检出率。
Cancer Med. 2023 May;12(10):11816-11827. doi: 10.1002/cam4.5850. Epub 2023 Mar 23.
6
Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.广州天河区结直肠癌筛查:粪便免疫化学检测与选择结肠镜检查患者的风险因素相结合的结果
Gastroenterol Rep (Oxf). 2018 May;6(2):132-136. doi: 10.1093/gastro/gox030. Epub 2017 Sep 5.
7
Performance of a colorectal cancer screening protocol in an economically and medically underserved population.经济和医疗资源匮乏人群中的结直肠癌筛查方案的效果。
Cancer Prev Res (Phila). 2011 Oct;4(10):1572-9. doi: 10.1158/1940-6207.CAPR-10-0377. Epub 2011 Sep 27.
8
Age- and sex-stratified detection rates and associated factors of colorectal neoplasia in the Tianjin colorectal cancer screening program from 2012 to 2020.2012 年至 2020 年天津市结直肠癌筛查项目中基于年龄和性别的结直肠肿瘤检出率及相关因素分析。
BMC Gastroenterol. 2023 Dec 12;23(1):435. doi: 10.1186/s12876-023-03060-3.
9
Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program.大规模项目中结直肠癌初步筛查方法的比较评估
Dig Dis Sci. 2017 Sep;62(9):2532-2541. doi: 10.1007/s10620-017-4648-1. Epub 2017 Jun 20.
10
Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).非综合征性结直肠癌患者一级亲属中结肠镜筛查与粪便免疫化学检测的应用率:一项多中心、开放标签、平行组、随机试验(ParCoFit 研究)。
PLoS Med. 2023 Oct 24;20(10):e1004298. doi: 10.1371/journal.pmed.1004298. eCollection 2023 Oct.

引用本文的文献

1
Fecal Immunochemical Testing for Colorectal Cancer Prevention in Two Public Hospitals.两家公立医院中用于预防结直肠癌的粪便免疫化学检测
J Gastrointest Cancer. 2025 Feb 22;56(1):69. doi: 10.1007/s12029-025-01187-y.
2
Genomic-Based Early Detection Screening: A Literature Review of Prospective Trials and Emerging Strategies for Gastrointestinal Cancers.基于基因组的早期检测筛查:胃肠道癌症前瞻性试验及新兴策略的文献综述
Cureus. 2024 Sep 7;16(9):e68881. doi: 10.7759/cureus.68881. eCollection 2024 Sep.
3
Colonoscopy compliance and diagnostic yield in a large population-based colorectal cancer screening programme.

本文引用的文献

1
Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea.抑郁和结构因素与腹泻型肠易激综合征患者的症状相关。
J Neurogastroenterol Motil. 2020 Sep 30;26(4):505-513. doi: 10.5056/jnm19166.
2
An early report of a screening program for colorectal cancer in Guangzhou, China.中国广州一项结直肠癌筛查项目的早期报告。
Ann Transl Med. 2019 Nov;7(21):604. doi: 10.21037/atm.2019.09.75.
3
Association of Medicaid expansion with health insurance coverage by marital status and sex.
结肠镜检查顺应性和在大型基于人群的结直肠癌筛查计划中的诊断收益。
Int J Colorectal Dis. 2023 Sep 13;38(1):227. doi: 10.1007/s00384-023-04517-3.
4
The accuracy of the FIT in detecting advanced neoplasm is highest in young people aged 40 to 49 years: an analysis based on sex and age.基于性别和年龄的分析显示,在 40 至 49 岁的年轻人中,粪便免疫化学检测(FIT)检测晚期肿瘤的准确性最高。
Int J Colorectal Dis. 2023 Jun 26;38(1):178. doi: 10.1007/s00384-023-04470-1.
5
Reply: Request for clarification on symptom assessment methodology in high-risk population colonoscopy study.回复:关于高危人群结肠镜检查研究中症状评估方法的澄清请求。
Cancer Med. 2023 Jul;12(14):15629-15631. doi: 10.1002/cam4.6164. Epub 2023 Jun 2.
医疗补助计划扩面与婚姻状况和性别相关的医疗保险覆盖情况的关联。
PLoS One. 2019 Oct 23;14(10):e0223556. doi: 10.1371/journal.pone.0223556. eCollection 2019.
4
Strategies for Colorectal Cancer Screening.结直肠癌筛查策略。
Gastroenterology. 2020 Jan;158(2):418-432. doi: 10.1053/j.gastro.2019.06.043. Epub 2019 Aug 5.
5
Barriers of colorectal cancer screening in rural USA: a systematic review.美国农村地区结直肠癌筛查的障碍:一项系统综述
Rural Remote Health. 2019 Aug;19(3):5181. doi: 10.22605/RRH5181. Epub 2019 Aug 9.
6
Mass screening for colorectal cancer in a population of two million older adults in Guangzhou, China.在中国广州,对两百万名老年人群进行结直肠癌大规模筛查。
Sci Rep. 2019 Jul 18;9(1):10424. doi: 10.1038/s41598-019-46670-2.
7
Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.短信干预措施对初步结直肠癌筛查结果阳性者进行结肠镜检查的效果:一项随机对照试验。
Cancer. 2019 Jul 1;125(13):2252-2261. doi: 10.1002/cncr.32043. Epub 2019 Mar 2.
8
Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.影响粪便潜血试验呈阳性的韩国人结肠镜检查行为的因素。
Eur J Cancer Care (Engl). 2019 Mar;28(2):e13008. doi: 10.1111/ecc.13008. Epub 2019 Feb 12.
9
[Report of cancer epidemiology in China, 2015].《2015年中国癌症流行病学报告》
Zhonghua Zhong Liu Za Zhi. 2019 Jan 23;41(1):19-28. doi: 10.3760/cma.j.issn.0253-3766.2019.01.005.
10
Assessment of Preventive Behavior for Cervical Cancer with the Health Belief Model.运用健康信念模式评估宫颈癌预防行为
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2155-2163. doi: 10.22034/APJCP.2018.19.8.2155.